| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/27/2005 | EP1039931B1 Multivalent recombinant antibodies for treating hrv infections |
| 04/27/2005 | EP1034173B1 Method for producing 8-methoxy-quinoline carboxylic acids |
| 04/27/2005 | EP0939818B1 Recombinant toxin fragments |
| 04/27/2005 | EP0910572B1 Inhibitors of picornavirus 3c proteases and methods for their use and preparation |
| 04/27/2005 | EP0906307B1 Substituted imidazoles having cytokine inhibitory activity |
| 04/27/2005 | EP0873519A4 Hiv protease inhibitors |
| 04/27/2005 | EP0838453B1 Heterocyclic carboxylic acid derivatives and drugs containing the same |
| 04/27/2005 | CN1610748A Recombinant MVA capable of expressing structural HCV antigens |
| 04/27/2005 | CN1610697A E type hepatitis virus monoclonal antibody or its conjugated active fragment and use thereof |
| 04/27/2005 | CN1610692A Process for preparing glycopeptide derivatives |
| 04/27/2005 | CN1610675A Benzothiazole- and benzoxazole-4, 7-dione derivatives and their use as CDC25 phosphatase inhibitors |
| 04/27/2005 | CN1610674A Use of 2-amino-thiazoline derivatives as inhibitors of inducible NO-synthase |
| 04/27/2005 | CN1610669A Heteroaryl-substituted aminocyclohexane derivatives |
| 04/27/2005 | CN1610667A 3-nitropyridine derivaives and the pharmaceutical compositions containing said derivatives |
| 04/27/2005 | CN1610661A Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 04/27/2005 | CN1610560A Multivalent meningococcal polysaccharide-protein conjugate vaccine |
| 04/27/2005 | CN1610553A Nucleic acid-based compounds and methods of use thereof |
| 04/27/2005 | CN1610546A 病毒聚合酶抑制剂 Viral polymerase inhibitor |
| 04/27/2005 | CN1610502A Surfactant protein for the prevention and diagnosis of pulmonary emphysema |
| 04/27/2005 | CN1609206A Crystal structure of oxidosqualene cyclase |
| 04/27/2005 | CN1609204A Bivalent hepatitis B-encephalitis B vaccine |
| 04/27/2005 | CN1609123A Variable region sequence of hepatitis B virus monoclonal antibody, gene engineering antibody containing the variable region and its use |
| 04/27/2005 | CN1609121A Antibiotic peptides and their prepn process and application |
| 04/27/2005 | CN1609119A Peptide library, its synthesis process and active segment screened from the peptide library |
| 04/27/2005 | CN1609118A Cell wall acyl-alanyl-D-isoglutamine derivative and its prepn, medicine composition and use |
| 04/27/2005 | CN1609113A Effective cowberry part for treating respiratory tract disease and its prepn process |
| 04/27/2005 | CN1608673A Prepn process of S190 polypeptide vaccine and its application in resisting SARS virus |
| 04/27/2005 | CN1608669A Filming aerosol for treating tinea coporis, tinea manuum and tinea pedis |
| 04/27/2005 | CN1608665A Blattbulume extract and its prepn process and application |
| 04/27/2005 | CN1608658A Hepatitis treating Chinese medicine prepn and its production process |
| 04/27/2005 | CN1608654A Chinese medicine for treating intrapulmonic infection and SARS |
| 04/27/2005 | CN1608648A Antiseptic Chinese medicine composition and its prepn process |
| 04/27/2005 | CN1608646A Wolfberry fruit-astragalus root oral liquid and its prepn process |
| 04/27/2005 | CN1608630A New use of hydrazine hydrate in treating tinea unguium |
| 04/27/2005 | CN1608627A SARS preventing medicine |
| 04/27/2005 | CN1608624A Cefpoxime proxetil for clinical injection |
| 04/27/2005 | CN1608620A Solid bicyclic alcohol dispersion |
| 04/27/2005 | CN1608619A Medicine recipe with baicalin |
| 04/27/2005 | CN1608615A Fibrauretine-amino acid fluid for transfusion and its production process |
| 04/27/2005 | CN1608613A Fibrauretine powder for injection and its production process |
| 04/27/2005 | CN1198933C Epitopes of protein pre-M/M of dengue virus, synthetic peptides |
| 04/27/2005 | CN1198932C Streptococcus pneumoniae antigens |
| 04/27/2005 | CN1198931C MOraxella catarrhalis BASB034 polypeptides and uses thereof |
| 04/27/2005 | CN1198918C Live attenuated bacteria of species actinobacillus pleuropneumoniae |
| 04/27/2005 | CN1198840C Human papillomavirus 11L1-E7 recombinant protein and its application |
| 04/27/2005 | CN1198838C Antipicornaviral compounds, their prepn. and use |
| 04/27/2005 | CN1198833C Vinyl pyrrolidone cephlosporins with basic substitutent group |
| 04/27/2005 | CN1198818C Compound with growth hormone releasing properties |
| 04/27/2005 | CN1198808C Use of benzotriazole UV absorbers |
| 04/27/2005 | CN1198804C Amide compounds and use thereof |
| 04/27/2005 | CN1198656C Dual action 2', 5'-oligoadenylate antiviral derivatives and uses thereof |
| 04/27/2005 | CN1198648C High affinity human monoclonal antibodies specific for RSV F-protein |
| 04/27/2005 | CN1198615C Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts of hydrates |
| 04/27/2005 | CN1198611C Anti-bacterial medicinal compositions |
| 04/27/2005 | CN1198589C Method for controlling liposome size |
| 04/27/2005 | CN1198563C Acidified composition for topical treatment of nail and skin conditions |
| 04/26/2005 | US6884907 Containing carboxylic acid groups; diagnosis; prophylaxis |
| 04/26/2005 | US6884868 Cyclic hexapeptides having antibiotic activity |
| 04/26/2005 | US6884813 Microbiocides used to treat eye and skin infections |
| 04/26/2005 | US6884808 Acids and salts such as 4-(4-(2-(2-(5,6,7,8-Tetrahydro-5,5,8, 8-tetramethylquinoxalyl))pyrrolyl))benzoic acid, used retinoic acid receptor agonists for the prophylaxis of cancer, skin disorders, asthma, alopecia or autoimmune diseases |
| 04/26/2005 | US6884804 Inhibitors of Src and other protein kinases |
| 04/26/2005 | US6884802 Phenanthridines substituted in position 6 by a mono, bi- or tricyclic heteroaryl radical; cyclic nucleotidephosphoesterase (PDE4) inhibitor and useful for treating respiratory system disorders |
| 04/26/2005 | US6884800 Nitrogen compounds such as 10-Chloro-3-imidazol-1-yl-2,3-dihydro-1H-pyrido(3,2,1-kl)phenothiazine, used for prophylaxis of respiratory system and skin disorders, autoimune diseases, tumors or atherosclerosis and AIDS |
| 04/26/2005 | US6884786 Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 04/26/2005 | US6884774 Cyclic hexapeptide derivatives |
| 04/26/2005 | US6884623 Using plant virions for vaccine preparation; gene therapy |
| 04/26/2005 | US6884440 Sodium metasilicate, borax,sodium thiosulfate, potassium carbonate, refined cane sugar and water; improvement in disease resistance, weight gain rate, crop yield, crop quality, and harvest time |
| 04/26/2005 | US6884433 Time release agents comprising drugs such as tacrolimus in solid solutions |
| 04/26/2005 | US6884422 Freeze-dried hepatitis A attenuated live vaccine and its stabilizer |
| 04/26/2005 | US6884412 Dectection of and methods and composition for prevention and/or treatment of papillomatous digital dermatitis |
| 04/26/2005 | US6884408 Delivery of diphenhydramine through an inhalation route |
| 04/26/2005 | CA2209487C Imidazo[4,5-c]quinoline amines |
| 04/21/2005 | WO2005035754A1 Double specific antibodies substituting for functional protein |
| 04/21/2005 | WO2005035546A1 Peptide nucleic acid conjugates and uses thereof |
| 04/21/2005 | WO2005035536A1 Novel xanthone derivative, process for producing the same and pharmaceutical composition containing the same |
| 04/21/2005 | WO2005035534A1 Heterocyclic bicyclo ring and heterocyclic tricyclo ring compounds and drugs comprising the same |
| 04/21/2005 | WO2005035528A2 Triazole derivatives as antibacterial agents |
| 04/21/2005 | WO2005035503A1 Novel isoquinoline derivative |
| 04/21/2005 | WO2005034993A1 Vp1 fusion protein vaccin of recombinant foot-and-mouth disease virus |
| 04/21/2005 | WO2005034971A2 Antiviral agent |
| 04/21/2005 | WO2005034957A1 Noncrystalline antibacterial composition containing cefditoren pivoxil |
| 04/21/2005 | WO2005034956A1 Antimycotic nail polish formulations comprising substituted 2-aminothiazoles as an active substance |
| 04/21/2005 | WO2005034941A1 Indoles and azaindoles as antiviral agents |
| 04/21/2005 | WO2005034934A1 Pharmaceutical formulations of xanthogenates and inhibitors of viral nucleic acid replication (e.g. aciclovir) |
| 04/21/2005 | WO2005034933A1 Inhibitors of yeast filamentous growth and method of their manufacture |
| 04/21/2005 | WO2005034838A2 Protease inhibitors |
| 04/21/2005 | WO2005021568A3 Novel tricyclic nucleosides or nucleotides as therapeutic agents |
| 04/21/2005 | WO2005017129B1 Phosphoramide and uses thereof |
| 04/21/2005 | WO2005012210A3 Antimicrobial active preparations containing terpene derivatives |
| 04/21/2005 | WO2004108940A3 Viral genome vectors |
| 04/21/2005 | WO2004100973A3 Pharmaceutical compositions of antithrombin iii for the treatment of retroviral diseases. |
| 04/21/2005 | WO2004080398A3 1-amino 1h-imidazoquinolines |
| 04/21/2005 | WO2004041156A3 Method for determining sensitivity to a bacteriophage |
| 04/21/2005 | WO2004009802A3 gM-NEGATIVE EHV-MUTANTS WITHOUT HETEROLOGOUS ELEMENTS |
| 04/21/2005 | WO2004005313A3 Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules |
| 04/21/2005 | WO2003048349A8 Acetoacetyl-coa thiolase and use of for the identification of novel fungicidal substances |
| 04/21/2005 | WO2002057425A3 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 04/21/2005 | US20050085639 Circulation disorders; antiproliferative agents; hypotensive agents; cardiovascular disorders; antiischemic agents; kidney disorders; atherosclerosis; restenosis; antiinflammatory agents; respiratory system disorders; angiogenesis inhibitors; anticancer agents; antiulcer agents |
| 04/21/2005 | US20050085549 Hetrocyclic aryl sulphonamides |
| 04/21/2005 | US20050085513 Baccatin III analog conjugated to cell binding agent such as monoclonal antibody through a link from the oxygen atom at the C-7 position; treating cancer, rheumatoid arthritis, transplant rejection, viral and parasite infections |